23.01.2014 • NewsDede WillamsOxeaOxsoft GPO

Oxea Lifts Output of Specialty Esters in Amsterdam

Dallas, Texas-based chemical producer Oxea has widened its capacity for specialty esters at Amsterdam, The Netherlands, by 20%.

The company said its investment, designed to specifically benefit producers of medical devices and flooring looking to replace phthalate-based plasticizers, was in the "single-digit million euro range."

"The increasing demand for phthalate-free plasticizers reaffirms the strategic vision of Oxea and the necessity of continuous investments and initiatives that we have embarked upon to address the industry's changing requirements," said

Cristobal Ascencio, global vice president for oxo derivatives at Oxea.

The company, which also has a base at Oberhausen, Germany, produces several phthalate-free plasticizers at the Amsterdam plant, including Oxsoft TOTM (trioctyl trimellitate) and DOTP (dioctyl terephthalate), marketed under the brand name Oxsoft GPO

 

Company

Logo:

Oxea

Rheinpromenade 4a
40789 Monheim am Rhein
Germany

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.